187 related articles for article (PubMed ID: 24618769)
1. A(nother) scientific strategy to prevent breast cancer in postmenopausal women by enhancing estrogen-induced apoptosis?
Jordan VC
Menopause; 2014 Oct; 21(10):1160-4. PubMed ID: 24618769
[TBL] [Abstract][Full Text] [Related]
2. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
3. Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.
Pinkerton JV; Stovall DW
Expert Opin Investig Drugs; 2010 Dec; 19(12):1613-21. PubMed ID: 21073353
[TBL] [Abstract][Full Text] [Related]
4. Using bazedoxifene plus conjugated estrogens for treating postmenopausal women: a comprehensive review.
Taylor HS; Ohleth K
Menopause; 2012 Apr; 19(4):479-85. PubMed ID: 22278343
[TBL] [Abstract][Full Text] [Related]
5. Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality.
Obiorah I; Jordan VC
Menopause; 2013 Apr; 20(4):372-82. PubMed ID: 23921472
[TBL] [Abstract][Full Text] [Related]
6. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
7. Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators.
Pinkerton JV; Conner EA
Climacteric; 2019 Apr; 22(2):140-147. PubMed ID: 30895900
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.
Pinkerton JV; Abraham L; Bushmakin AG; Cappelleri JC; Racketa J; Shi H; Chines AA; Mirkin S
J Womens Health (Larchmt); 2014 Jan; 23(1):18-28. PubMed ID: 24206058
[TBL] [Abstract][Full Text] [Related]
9. Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.
Lewiecki EM
Expert Opin Investig Drugs; 2007 Oct; 16(10):1663-72. PubMed ID: 17922629
[TBL] [Abstract][Full Text] [Related]
10. Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.
Stovall DW; Tanner-Kurtz K; Pinkerton JV
Drugs; 2011 Sep; 71(13):1649-57. PubMed ID: 21902289
[TBL] [Abstract][Full Text] [Related]
11. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
[TBL] [Abstract][Full Text] [Related]
12. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
[TBL] [Abstract][Full Text] [Related]
13. Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women.
Yu H; Racketa J; Chines AA; Mirkin S
Climacteric; 2013 Apr; 16(2):252-7. PubMed ID: 23035721
[TBL] [Abstract][Full Text] [Related]
14. Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture.
Rossini M; Lello S; Sblendorio I; Viapiana O; Fracassi E; Adami S; Gatti D
Drug Des Devel Ther; 2013; 7():601-10. PubMed ID: 23901263
[TBL] [Abstract][Full Text] [Related]
15. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
Palacios S; Currie H; Mikkola TS; Dragon E
Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
[TBL] [Abstract][Full Text] [Related]
16. Time to transient and stable reductions in hot flush frequency in postmenopausal women using conjugated estrogens/bazedoxifene.
Pinkerton JV; Bushmakin AG; Abraham L; Komm BS; Bobula J
Menopause; 2017 Sep; 24(9):1011-1016. PubMed ID: 28463874
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.
Palacios S; Arias L; Lavenberg J; Pan K; Mirkin S; Komm BS
Climacteric; 2016 Jun; 19(3):261-7. PubMed ID: 26940720
[TBL] [Abstract][Full Text] [Related]
18. Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial.
Chlebowski RT; Barrington W; Aragaki AK; Manson JE; Sarto G; OʼSullivan MJ; Wu D; Cauley JA; Qi L; Wallace RL; Prentice RL
Menopause; 2017 Feb; 24(2):133-141. PubMed ID: 27749739
[TBL] [Abstract][Full Text] [Related]
19. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
20. The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms.
Kagan R
J Womens Health (Larchmt); 2012 Sep; 21(9):975-81. PubMed ID: 22759213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]